Biochemical Diagnosis of Cerebrotendinous Xanthomatosis Using Reversed Phase Thin Layer Chromatography1
- 1 March 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 99 (3) , 771-775
- https://doi.org/10.1093/oxfordjournals.jbchem.a135536
Abstract
We developed a simple quantitative procedure for cholestanol in serum involving reversed phase thin layer chromatography. This procedure was satisfactory with regard to the linearity of the calibration curve in the range of 100 ng to 1,000 ng, recovery and reproducibility. Only 100 μl of serum was needed for determination of the cholestanol concentration. Prior to thin layer chromatography, cholesterol was converted to α- and β -epoxides with m -chloroperbenzoic acid, which were clearly distinguishable from cholestanol on TLC. Detection of sterols was performed by spraying with phosphomolybdic acid solution. Quantification of cholestanol was carried out with a TLC scanning densitometer. When serum cholestanol in cerebrotendinous xanthomatosis (CTX) patients was quantified by TLC, GC-MS, and GC, the correlation among the three methods was found to be approximately 1 : 1 : 1. It was found that the present method was useful for the primary diagnostic screening of CTX because of its simplicity and because many samples could be analyzed at one time.This publication has 4 references indexed in Scilit:
- Simplified Determination of Cholestanol in Serum by Gas-Liquid Chromatography: Biochemical Diagnosis of Cerebrotendinous Xanthomatosis1The Journal of Biochemistry, 1981
- Quantitative Determination of Cholestanol in Plasma with Mass Fragmentography: Biochemical Diagnosis of Cerebrotendinous Xanthomatosis1The Journal of Biochemistry, 1976
- DIRECT QUANTITATION OF CHOLESTANOL IN PLASMA BY GAS-LIQUID-CHROMATOGRAPHY1976
- Cholestanol Deposition in Cerebrotendinous XanthomatosisAnnals of Internal Medicine, 1971